Abstract

Background. This study aimed to examine early clinical and laboratory findings in infants born to mothers who had organ transplants and received immunosuppressive treatment.

Methods. Between 2016 and 2023, the study examined infants of mothers who underwent organ transplantation and were receiving immunosuppressive treatment, and followed at the Department of Neonatology at Akdeniz University. Demographic, clinical, and laboratory characteristics of mothers and infants were recorded. On the first day of life, complete blood count values were examined, as well as potassium levels on the first, third, and seventh days, and creatinine levels on the third and seventh days. The tacrolimus blood level was calculated by taking the average of the tacrolimus blood values of the mother measured during the pregnancy. The infants were evaluated for any potential morbidities caused by intrauterine immunosuppressive drug exposure.

Results. The study included 21 mothers (some with multiple pregnancies) and 27 infants. According to the findings of this study, 74% of these infants were born premature, 67% had low birth weight, and all were delivered via cesarean section. Prematurity was associated with the morbidities found in the infants. In the early period, lymphopenia was detected in 37%, neutropenia in 25.9%, thrombocytopenia in 11.1%, hyperkalemia in 18.5%, and creatinine elevation in 7.4%, all of which returned to normal within a few days. There was no significant relationship between maternal tacrolimus blood levels and infant potassium and creatinine levels.

Conclusion. Apart from an increased risk of prematurity, low birth weight, and cesarean delivery, no effects were observed in these infants during the early period. However, long-term follow-up is necessary to monitor for any potential morbidities.

Keywords: organ transplantation, pregnancy, immunosuppressive treatment, prematurity

Copyright and license

Copyright © 2024 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Çelik K, Arayıcı S, Özkan Zarif N, Kıhtır Z, Ongun H, Aydınlı B. Early neonatal outcomes in infants of mothers with organ transplantation under immunosuppressive treatment. Turk J Pediatr 2024; 66: 17-24. https://doi.org/10.24953/turkjped.2023.748

References

  1. Boulay H, Mazaud-Guittot S, Supervielle J, et al. Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review. Clin Kidney J 2021; 14: 1871-1878. https://doi.org/10.1093/ckj/sfab049
  2. McKinzie CJ, Casale JP, Guerci JC, Prom A, Doligalski CT. Outcomes of Children with Fetal and Lactation Immunosuppression Exposure Born to Female Transplant Recipients. Paediatr Drugs 2022; 24: 483-497. https://doi.org/10.1007/s40272-022-00525-y
  3. Meinderts JR, Prins JR, Berger SP, De Jong MFC. Follow-Up of Offspring Born to Parents With a Solid Organ Transplantation: A Systematic Review. Transpl Int 2022; 35: 10565. https://doi.org/10.3389/ti.2022.10565
  4. McKay DB, Josephson MA. Pregnancy after kidney transplantation. Clin J Am Soc Nephrol 2008; 3(Suppl 2): S117-S125. https://doi.org/10.2215/CJN.02980707
  5. Hebert MF, Zheng S, Hays K, et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation 2013; 95: 908-915. https://doi.org/10.1097/TP.0b013e318278d367
  6. Grimer M; Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Calcineurin inhibitors in renal transplantation: pregnancy, lactation and calcineurin inhibitors. Nephrology (Carlton) 2007; 12(Suppl 1:) S98-S105. https://doi.org/10.1111/j.1440-1797.2006.00735.x
  7. Blom M, Pico-Knijnenburg I, van Montfrans JM, et al. Abnormal Results of Newborn Screening for SCID After Azathioprine Exposure In Utero: Benefit of TPMT Genotyping in Both Mother and Child. J Clin Immunol 2022; 42: 199-202. https://doi.org/10.1007/s10875-021-01138-9
  8. Cleary BJ, Källén B. Early pregnancy azathioprine use and pregnancy outcomes. Birth Defects Res A Clin Mol Teratol 2009; 85: 647-654. https://doi.org/10.1002/bdra.20583
  9. Schmutz N, Henry E, Jopling J, Christensen RD. Expected ranges for blood neutrophil concentrations of neonates: the Manroe and Mouzinho charts revisited. J Perinatol 2008; 28: 275-281. https://doi.org/10.1038/sj.jp.7211916
  10. Henry E, Christensen RD. Reference Intervals in Neonatal Hematology. Clin Perinatol 2015; 42: 483-497. https://doi.org/10.1016/j.clp.2015.04.005
  11. Bateman DA, Thomas W, Parravicini E, Polesana E, Locatelli C, Lorenz JM. Serum creatinine concentration in very-low-birth-weight infants from birth to 34-36 wk postmenstrual age. Pediatr Res 2015; 77: 696-702. https://doi.org/10.1038/pr.2015.25
  12. Boer DP, de Rijke YB, Hop WC, Cransberg K, Dorresteijn EM. Reference values for serum creatinine in children younger than 1 year of age. Pediatr Nephrol 2010; 25: 2107-2113. https://doi.org/10.1007/s00467-010-1533-y
  13. IF-ELSE-Wong KM, Bailey RR, Lynn KL, Robson RA, Abbott GD. Pregnancy in renal transplant recipients: the Christchurch experience. N Z Med J 1995; 108: 190-192.
  14. Devresse A, Jassogne C, Hubinont C, et al. Pregnancy Outcomes After Kidney Transplantation and Long-Term Evolution of Children: A Single Center Experience. Transplant Proc 2022; 54: 652-657. https://doi.org/10.1016/j.transproceed.2022.01.019
  15. Kociszewska-Najman B, Pietrzak B, Moneta-Wielgos J, Samaha R, Wielgos M. Study of the ophthalmic system of babies delivered to transplant recipients. Transplantation 2013; 95: 847-851. https://doi.org/10.1097/TP.0b013e31827f84db
  16. Bachmann F, Budde K, Gerland M, et al. Pregnancy following kidney transplantation - impact on mother and graft function and focus on childrens’ longitudinal development. BMC Pregnancy Childbirth 2019; 19: 376. https://doi.org/10.1186/s12884-019-2496-z
  17. Borek-Dziecioł B, Czaplinska N, Szpotanska-Sikorska M, et al. Selected Biochemical Parameters in Children of Mothers After Kidney Transplantation. Transplant Proc 2020; 52: 2294-2298. https://doi.org/10.1016/j.transproceed.2020.02.100
  18. Czaplińska N, Kociszewska-Najman B, Schreiber-Zamora J, et al. Analysis of the selected biochemical parameters of liver and kidney function in children of mothers after liver transplantation. Transplant Proc 2014; 46: 2790-2793. https://doi.org/10.1016/j.transproceed.2014.09.059
  19. Aktürk S, Sadioğlu RE, Şengül Ş, Keven K. Acute kidney injury in an infant of a kidney allograft recipient. Clin Kidney J 2019; 13: 123-124. https://doi.org/10.1093/ckj/sfz093
  20. de Boer NK, Jarbandhan SV, de Graaf P, Mulder CJ, van Elburg RM, van Bodegraven AA. Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites. Am J Gastroenterol 2006; 101: 1390-1392. https://doi.org/10.1111/j.1572-0241.2006.00538.x
  21. Flanagan E, Wright EK, Hardikar W, et al. Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates. Aliment Pharmacol Ther 2021; 53: 810-820. https://doi.org/10.1111/apt.16294
  22. Bar J, Stahl B, Hod M, Wittenberg C, Pardo J, Merlob P. Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience. Am J Med Genet A 2003; 116A: 31-36. https://doi.org/10.1002/ajmg.a.10817
  23. Ono E, Dos Santos AM, Viana PO, et al. Immunophenotypic profile and increased risk of hospital admission for infection in infants born to female kidney transplant recipients. Am J Transplant 2015; 15: 1654-1665. https://doi.org/10.1111/ajt.13143
  24. Egerup P, Carlson N, Bruun Oestergaard L, et al. Increased risk of neonatal complications and infections in children of kidney-transplanted women: A nationwide controlled cohort study. Am J Transplant 2021; 21: 1171-1178. https://doi.org/10.1111/ajt.16259
  25. Platt MJ. Outcomes in preterm infants. Public Health 2014; 128: 399-403. https://doi.org/10.1016/j.puhe.2014.03.010
  26. Schreiber-Zamora J, Szpotanska-Sikorska M, Czaplinska N, et al. Evaluation of the body mass index (BMI) in children born to organ transplant recipients. J Matern Fetal Neonatal Med 2019; 32: 2512-2516. https://doi.org/10.1080/14767058.2018.1439468
  27. Schreiber-Zamora J, Szpotanska-Sikorska M, Drozdowska-Szymczak A, et al. Neurological development of children born to mothers after kidney transplantation. J Matern Fetal Neonatal Med 2019; 32: 1523-1527. https://doi.org/10.1080/14767058.2017.1407754